2
40
Growth Score
0 pts
Heat Score
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
589137
Cambrex is a small molecule company that offers drug substance, drug product, and analytical services.
Robert Green: EVP & Chief Financial OfficerPast Role: GE Capital, CFO of GE Capital EMEA- Shawn Cavanagh: Executive Vice President and Chief Operating Officer
About the Company
Cambrex is a small molecule company that offers drug substance, drug product, and analytical services. The company provides an end-to-end partnership for the research, development, and manufacture of small molecule therapeutics at every stage of the lifecycle. With years of experience and a growing team of experts servicing global clients, the
company is tried and trusted in branded and generic markets for API and dosage form development and manufacturing.
It was founded on 1981 and is headquartered in East Rutherford, New Jersey.
